7 June 2020

URV Activ@ - Diari digital de la Universitat Rovira i Virgili ·

Advanced search

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”

The results of the PREDIMED study suggest that the most up-to-date recommendations of the international organisation World Cancer Research Fund/American Institute for Cancer Research to maintain a healthy lifestyle reduce the risk of colorectal in older people with a high cardiovascular risk. The results of the study have been published in the “Journal of Clinical Medicine”